Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Millennium Pharmaceuticals and Harvard Medical School's Office of Technology Development have signed an innovative collaboration agreement to pursue a research program in the area of protein homeostasis, an emerging and expanding field of cancer biology.
Subscribe to our email newsletter
Under the terms of the agreement, Harvard has granted Millennium a license to certain invention from the laboratory of Wade Harper and the two institutions will jointly advance the program in this novel area of research over several years under a sponsored research agreement. Research has shown various pathways that regulate cellular protein homeostasis are linked to the pathologic properties of a broad range of cancers. The initial research-based agreement is focused on advancing knowledge in this evolving field over the course of three years.
Joe Bolen, chief scientific officer of Millennium, said: “Our mutual interest in advancing this promising area of research will provide the opportunity to apply our combined knowledge and expertise and may ultimately lead to a new generation of therapies for patients.”